載入...
Targeting Remission in Moderate-to-Severe Crohn’s Disease
Therapeutic options in development for the treatment of Crohn’s disease represent a broad range of approaches to this complex disease. This active pipeline contains a combination of both small-molecule entities and targeted monoclonal antibodies.
Na minha lista:
| 發表在: | P T |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MediMedia USA, Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5969213/ https://ncbi.nlm.nih.gov/pubmed/29896035 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|